(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-28 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 143454
Date | Daily Closing Price | Open | High | Low | Volume |
28 Wed Aug 2024 | 7.53 | 7.40 | 7.66 | 7.39 | 0.727 times |
27 Tue Aug 2024 | 7.47 | 7.53 | 7.66 | 7.44 | 0.455 times |
26 Mon Aug 2024 | 7.68 | 7.50 | 7.83 | 7.50 | 0.841 times |
23 Fri Aug 2024 | 7.53 | 7.19 | 7.89 | 7.15 | 1.248 times |
22 Thu Aug 2024 | 7.17 | 7.30 | 7.55 | 7.16 | 0.66 times |
21 Wed Aug 2024 | 7.27 | 7.15 | 7.27 | 7.06 | 0.689 times |
20 Tue Aug 2024 | 7.10 | 7.19 | 7.39 | 7.05 | 1.679 times |
19 Mon Aug 2024 | 7.16 | 7.64 | 7.70 | 7.16 | 1.684 times |
16 Fri Aug 2024 | 7.71 | 7.57 | 8.09 | 7.49 | 1.378 times |
15 Thu Aug 2024 | 7.68 | 7.45 | 7.78 | 7.45 | 0.409 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 7.6 as stoploss in an intra day sell trade for a target of 7.39. However, stock will show a bullish move above 7.6.
Share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Target | 6.65 |
Downside Target | 6.80 |
Downside Target | 7.24 |
Downside Target | 7.39 |
Upside Target | 7.55 |
Upside Target | 7.80 |
Upside Target | 8.00 |
Upside Target | 8.09 |
Upside Target | 8.52 |
Upside Target | 9.12 |
Upside Target | 9.25 |
Upside Target | 12.85 |
Intraday share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Intraday Target | 7.34 |
Downside Intraday Target | 7.14 |
Upside Intraday Target | 7.78 |
Upside Intraday Target | 8.02 |
Upside Intraday Target | 7.58 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
Date | Weekly Closing Price | Open | High | Low | Volume |
28 Wed Aug 2024 | 7.53 | 7.50 | 7.83 | 7.39 | 0.339 times |
23 Fri Aug 2024 | 7.53 | 7.64 | 7.89 | 7.05 | 1.302 times |
16 Fri Aug 2024 | 7.71 | 7.34 | 8.09 | 7.24 | 0.777 times |
09 Fri Aug 2024 | 7.34 | 6.99 | 7.55 | 6.90 | 0.934 times |
02 Fri Aug 2024 | 7.33 | 8.43 | 8.52 | 6.98 | 0.99 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
Date | Monthly Closing Price | Open | High | Low | Volume |
28 Wed Aug 2024 | 7.53 | 7.75 | 8.09 | 6.90 | 0.688 times |
31 Wed Jul 2024 | 7.75 | 7.37 | 9.25 | 6.93 | 0.924 times |
28 Fri Jun 2024 | 7.38 | 7.07 | 8.00 | 6.65 | 0.835 times |
31 Fri May 2024 | 7.07 | 8.93 | 9.12 | 6.80 | 0.678 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.39 and Outlook Therapeutics (OTLK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.39 and Outlook Therapeutics (OTLK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.